全文获取类型
收费全文 | 1404969篇 |
免费 | 121834篇 |
国内免费 | 11499篇 |
专业分类
耳鼻咽喉 | 17495篇 |
儿科学 | 43740篇 |
妇产科学 | 37691篇 |
基础医学 | 192280篇 |
口腔科学 | 37589篇 |
临床医学 | 130125篇 |
内科学 | 286980篇 |
皮肤病学 | 32802篇 |
神经病学 | 113927篇 |
特种医学 | 58482篇 |
外国民族医学 | 327篇 |
外科学 | 217717篇 |
综合类 | 42001篇 |
现状与发展 | 22篇 |
一般理论 | 435篇 |
预防医学 | 110598篇 |
眼科学 | 30897篇 |
药学 | 101413篇 |
70篇 | |
中国医学 | 6278篇 |
肿瘤学 | 77433篇 |
出版年
2019年 | 11861篇 |
2018年 | 16361篇 |
2017年 | 13125篇 |
2016年 | 15359篇 |
2015年 | 18000篇 |
2014年 | 24536篇 |
2013年 | 33759篇 |
2012年 | 42185篇 |
2011年 | 45295篇 |
2010年 | 28343篇 |
2009年 | 26865篇 |
2008年 | 40463篇 |
2007年 | 42773篇 |
2006年 | 43926篇 |
2005年 | 42405篇 |
2004年 | 39350篇 |
2003年 | 38197篇 |
2002年 | 35758篇 |
2001年 | 67543篇 |
2000年 | 69315篇 |
1999年 | 58169篇 |
1998年 | 17201篇 |
1997年 | 15415篇 |
1996年 | 16133篇 |
1995年 | 17036篇 |
1994年 | 15780篇 |
1993年 | 14533篇 |
1992年 | 47580篇 |
1991年 | 46171篇 |
1990年 | 44365篇 |
1989年 | 42141篇 |
1988年 | 39055篇 |
1987年 | 38309篇 |
1986年 | 36047篇 |
1985年 | 34794篇 |
1984年 | 26438篇 |
1983年 | 22135篇 |
1982年 | 13838篇 |
1981年 | 12446篇 |
1980年 | 11688篇 |
1979年 | 23561篇 |
1978年 | 17039篇 |
1977年 | 14345篇 |
1976年 | 13149篇 |
1975年 | 13705篇 |
1974年 | 16091篇 |
1973年 | 15396篇 |
1972年 | 14174篇 |
1971年 | 13032篇 |
1970年 | 11868篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
S. Liu A. E. Patanwala J. M. Naylor N. Levy R. Knaggs J. A. Stevens B. Bugeja D. Begley K. E. Khor E. Lau R. Allen S. Adie J. Penm 《Anaesthesia》2023,78(10):1237-1248
Modified-release opioids are often prescribed for the management of moderate to severe acute pain following total hip and knee arthroplasty, despite recommendations against their use due to increasing concerns regarding harm. The primary objective of this multicentre study was to examine the impact of modified-release opioid use on the incidence of opioid-related adverse events compared with immediate-release opioid use, among adult inpatients following total hip or knee arthroplasty. Data for total hip and knee arthroplasty inpatients receiving an opioid analgesic for postoperative analgesia during hospitalisation were collected from electronic medical records of three tertiary metropolitan hospitals in Australia. The primary outcome was the incidence of opioid-related adverse events during hospital admission. Patients who received modified with or without immediate-release opioids were matched to those receiving immediate-release opioids only (1:1) using nearest neighbour propensity score matching with patient and clinical characteristics as covariates. This included total opioid dose received. In the matched cohorts, patients given modified-release opioids (n = 347) experienced a higher incidence of opioid-related adverse events overall, compared with those given immediate-release opioids only (20.5%, 71/347 vs. 12.7%, 44/347; difference in proportions 7.8% [95%CI 2.3–13.3%]). Modified-release opioid use was associated with an increased risk of harm when used for acute pain during hospitalisation after total hip or knee arthroplasty. 相似文献
2.
Deitelzweig Steve Luo Xuemei Nguyen Jennifer L. Malhotra Deepa Emir Birol Russ Cristina Li Xiaoyan Lee Theodore C. Ferri Mauricio Wiederkehr Danny Reimbaeva Maya Barnes Geoffrey D. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(4):696-696
Journal of Thrombosis and Thrombolysis - 相似文献
3.
4.
5.
6.
7.
8.
Dong-Xin Hu Qi-Feng Sun Lin Xu Hong-Da Lu Fan Zhang Zhen-Miao Li Ming-Yan Zhang 《World journal of gastroenterology : WJG》2022,28(4):464-478
BACKGROUND Esophageal squamous cell carcinoma(ESCC)is one of the most prevalent malignancies that seriously threaten people’s health worldwide.DEAD-box helicase 51(DDX51)is a member of the DEAD-box(DDX)RNA helicase family,and drives or inhibits tumor progression in multiple cancer types.AIM To determine whether DDX51 affects the biological behavior of ESCC.METHODS The expression of DDX51 in ESCC tumor tissues and adjacent normal tissues was detected by Immunohistochemistry(IHC)analyses and quantitative PCR(qPCR).We knocked down DDX51 in ESCC cell lines by using a small interfering RNA(siRNA)transfection.The proliferation,apoptosis,and mobility of DDX51 siRNAtransfected cells were detected.The effect of DDX51 on the phosphoinositide 3-kinase(PI3K)/AKT pathway was investigated by western blot analysis.A mouse xenograft model was established to investigate the effects of DDX51 knockdown on ESCC tumor growth.RESULTS DDX51 exhibited high expression in ESCC tissues compared with normal tissues and represented a poor prognosis in patients with ESCC.Knockdown of DDX51 induced inhibition of ESCC cell proliferation and promoted apoptosis.Moreover,DDX51 siRNA-expressing cells also exhibited lower migration and invasion rates.Investigations into the underlying mechanisms suggested that DDX51 knock down induced inactivation of the PI3K/AKT pathway,including decreased phosphorylation levels of phosphate and tensin homolog,PI3K,AKT,and mammalian target of rapamycin.Rescue experiments demonstrated that the AKT activator insulin-like growth factor 1 could reverse the inhibitory effects of DDX51 on ESCC malignant development.Finally,we injected DDX51 siRNA-transfected TE-1 cells into an animal model,which resulted in slower tumor growth.CONCLUSION Our study suggests for the first time that DDX51 promotes cancer cell proliferation by regulating the PI3K/AKT pathway;thus,DDX51 might be a therapeutic target for ESCC. 相似文献
9.
韦氏三联九针是“燕京韦氏眼科学术流派”工作室团队治疗多种眼病,尤其是视神经视网膜退行性疾病的重要针灸处方,临床实践显示疗效较好。笔者对韦氏三联九针法的起源、选穴配穴思路,三联不同部位的针刺手法操作要领进行了解读,并对近年来的研究进展进行了详细阐述。提出在遵循针灸理论基础上,传承并发展的三联九针法,可较大程度提高针灸治疗眼病的疗效。 相似文献
10.
卫逸涛肖惠敏谢银环孙丽军 《中华健康管理学杂志》2022,(8):547-552
目的了解老年人生命晚期获知疾病相关信息意向及影响因素。方法2016年10月至2017年6月,采用生命晚期疾病信息意向问卷,利用方便抽样法对福州市中心城区7所养老机构及15个社区的414例年龄≥60岁的老年人进行横断面调查,采用单因素分析、多元线性回归与有序多分类logistic回归分析老年人对疾病相关信息的需求水平、获知程度意向及其影响因素。结果414例老年人疾病相关信息需求得分为(17.1±4.9)分;48.8%(202/414)希望详尽知晓,30.7%(127/414)希望选择性了解,20.5%(85/414)不想知道任何信息;多元线性回归分析显示,年龄、文化程度、是否接受/见过其他生命维持治疗(LSTs)是影响老年人疾病相关信息需求水平的主要因素(标准化回归系数分别为-0.141、0.116、0.115,均P<0.05);有序多分类logistic分析显示,年龄(以60~69岁为参照,70~79岁:OR=0.544,95%CI:0.310~0.957;80~89岁:OR=0.526,95%CI:0.289~0.956)、文化程度(以小学及以下为参照,大专及以上:OR=2.166,95%CI:1.093~4.290)、主要生活费来源(以其他补贴为参照,家人支持:OR=7.303,95%CI:1.157~46.108;退休金:OR=9.288,95%CI:1.502~57.415;公积金/储蓄:OR=15.676,95%CI:2.122~115.793)、是否接受/见过其他LSTs(以是为参照,OR=1.985,95%CI:1.150~3.425)是影响老年人疾病相关信息获知程度意向的主要因素。结论老年人生命晚期获知疾病相关信息的意向程度较高,年龄、文化程度、主要生活费来源、是否接受/见过其他生命维持治疗等是其主要影响因素。 相似文献